“The makers of three popular weight loss drugs, all of which have known physical and mental health risks, announced last week that they are testing the products for children as young as age 6.

Novo Nordisk, maker of Ozempic and Wegovy, and Eli Lilly, maker of Mounjaro, have approval for the drugs in the U.S. and European Union (EU) for people ages 12 and up.

Novo Nordisk is reportedly already in phase 3 trials with children 6-12, testing its Saxenda product, an older and less potent version of its bestselling drugs. Eli Lilly began recruiting children for its trials last week.”